Association of Tumor Microenvironment T-Cell Repertoire and Mutational Load With Clinical Outcome After Sequential Checkpoint Blockade in Melanoma

To understand prognostic factors for outcome between differentially sequenced nivolumab and ipilimumab in a randomized phase II trial, we measured T-cell infiltration and PD-L1 by immunohistochemistry, T-cell repertoire metrics, and mutational load within the tumor. We used next-generation sequencin...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancer Immunol Res
Glavni autori: Yusko, Erik, Vignali, Marissa, Wilson, Richard K., Mardis, Elaine R., Hodi, F. Stephen, Horak, Christine, Chang, Han, Woods, David M., Robins, Harlan, Weber, Jeffrey
Format: Artigo
Jezik:Inglês
Izdano: 2019
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6397694/
https://ncbi.nlm.nih.gov/pubmed/30635271
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-18-0226
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items